HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,371,149 | -54.4% | 27,850 | -55.7% | 0.09% | -28.1% |
| Q1 2023 | $5,203,486 | -10.6% | 62,882 | -15.0% | 0.12% | +21.0% |
| Q4 2022 | $5,817,976 | +6.2% | 73,973 | 0.0% | 0.10% | +7.5% |
| Q3 2022 | $5,476,000 | +24.1% | 73,973 | +6.0% | 0.09% | +8.1% |
| Q1 2022 | $4,412,000 | +11.9% | 69,787 | -6.1% | 0.09% | -16.5% |
| Q4 2021 | $3,943,000 | +22.9% | 74,347 | +63.6% | 0.10% | +74.6% |
| Q3 2021 | $3,207,000 | +427.5% | 45,437 | +397.7% | 0.06% | +436.4% |
| Q2 2021 | $608,000 | -62.8% | 9,129 | -38.0% | 0.01% | -60.7% |
| Q1 2021 | $1,635,000 | – | 14,727 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |